Generics - Anti-Arthritics/Rheumatics, Licensing

Filter

Popular Filters

EPIRUS and Livzon Mabpharm to develop biosimilars for China

EPIRUS and Livzon Mabpharm to develop biosimilars for China

25-09-2014

EPIRUS Biopharmaceuticals has signed a royalty-bearing, multi-product collaboration agreement with Livzon…

Anti-Arthritics/RheumaticsBiosimilarsBOW015ChinaEPIRUS BiopharmaceuticalsGastro-intestinalsGenericsLicensingLivzon MabpharmRemicadeResearch

Baxter and Coherus in up to $246 million deal for biosimilar etanercept

04-09-2013

US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

News briefs from Sanofi, EpiCept/Meda, Horizon/Grunenthal and Watson

20-06-2012

French drug major Sanofi (Euronext: SAN) and the Joslin Diabetes Center, a teaching and research affiliate…

AllerganAnti-Arthritics/RheumaticsCepleneDiabetesDuexisEpiCeptGenericsGenito-urinaryGrunenthalHorizon PharmaLicensingMedaOncologyPatentsPharmaceuticalResearchSanctura XRSanofiWatson Pharmaceuticals

Back to top